清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial

医学 全直肠系膜切除术 结直肠癌 直肠 新辅助治疗 外科肿瘤学 放化疗 外科 临床试验 入射(几何) 前瞻性队列研究 内科学 放射治疗 肿瘤科 癌症 物理 乳腺癌 光学
作者
Francesco Marchegiani,Valeria Palatucci,Giulia Capelli,Mario Guerrieri,Claudio Belluco,Daniela Rega,Emilio Morpurgo,Claudio Coco,Angelo Restivo,Silvia De Franciscis,Carlo Aschele,Alessandro Perin,Michele Bonomo,Andrea Muratore,Antonino Spinelli,Salvatore Ramuscello,Francesca Bergamo,Giampaolo Montesi,Gaya Spolverato,Paola Del Bianco
出处
期刊:Annals of Surgical Oncology [Springer Science+Business Media]
卷期号:29 (3): 1880-1889 被引量:43
标识
DOI:10.1245/s10434-021-11121-8
摘要

Rectum-preservation for locally advanced rectal cancer has been proposed as an alternative to total mesorectal excision (TME) in patients with major (mCR) or complete clinical response (cCR) after neoadjuvant therapy. The purpose of this study was to report on the short-term outcomes of ReSARCh (Rectal Sparing Approach after preoperative Radio- and/or Chemotherapy) trial, which is a prospective, multicenter, observational trial that investigated the role of transanal local excision (LE) and watch-and-wait (WW) as integrated approaches after neoadjuvant therapy for rectal cancer.Patients with mid-low rectal cancer who achieved mCR or cCR after neoadjuvant therapy and were fit for major surgery were enrolled. Clinical response was evaluated at 8 and 12 weeks after completion of chemoradiotherapy. Treatment approach, incidence, and reasons for subsequent TME were recorded.From 2016 to 2019, 160 patients were enrolled; mCR or cCR at 12 weeks was achieved in 64 and 96 of patients, respectively. Overall, 98 patients were managed with LE and 62 with WW. In the LE group, Clavien-Dindo 3+ complications occurred in three patients. The rate of cCR increased from 8- to 12-week restaging. Thirty-three (94.3%) of 35 patients with cCR had ypT0-1 tumor. At a median 24 months follow-up, a tumor regrowth was found in 15 (24.2%) patients undergoing WW.LE for patients achieving cCR or mCR is safe. A 12-week interval from chemoradiotherapy completion to LE is correlated with an increased cCR rate. The risk of ypT > is reduced when LE is performed after cCR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷你的蜜粉完成签到,获得积分10
13秒前
大个的应助被Gilgardea采纳,获得10
24秒前
汉堡包的应助被辅助但上分采纳,获得10
34秒前
忧郁凝阳完成签到,获得积分10
42秒前
整齐成协完成签到,获得积分10
47秒前
55秒前
冥土追魂完成签到,获得积分10
56秒前
冥土追魂发布了新的文献求助10
59秒前
丘比特的应助被武雨寒采纳,获得10
1分钟前
懵懂的小之完成签到,获得积分10
1分钟前
专注的怜珊完成签到,获得积分10
1分钟前
完美世界的应助被武雨寒采纳,获得10
1分钟前
科研通AI6.4的应助被cat采纳,获得10
1分钟前
1分钟前
羞涩的傲菡完成签到,获得积分10
1分钟前
武雨寒发布了新的文献求助10
1分钟前
兴奋乞完成签到,获得积分10
1分钟前
零度空间完成签到,获得积分10
1分钟前
痴情的不惜完成签到,获得积分10
1分钟前
1分钟前
整齐念薇完成签到,获得积分10
1分钟前
武雨寒发布了新的文献求助10
2分钟前
2分钟前
诸葛平卉完成签到 ,获得积分10
2分钟前
星辰大海的应助被psm采纳,获得10
2分钟前
2分钟前
飞天大南瓜完成签到,获得积分10
2分钟前
Gilgardea发布了新的文献求助10
2分钟前
车车完成签到 ,获得积分10
2分钟前
精明开山完成签到,获得积分10
2分钟前
2分钟前
鲤鱼遥完成签到,获得积分10
2分钟前
cat发布了新的文献求助10
2分钟前
AG完成签到,获得积分10
2分钟前
田田完成签到 ,获得积分10
2分钟前
2分钟前
等待凡英完成签到,获得积分10
2分钟前
陈荆洲完成签到,获得积分10
2分钟前
高高的玉兰完成签到,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166413
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750478
捐赠科研通 7757221
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553489
邀请新用户注册赠送积分活动 2473835